4.8 Article

Molecular basis of GID4-mediated recognition of degrons for the Pro/N-end rule pathway

期刊

NATURE CHEMICAL BIOLOGY
卷 14, 期 5, 页码 466-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41589-018-0036-1

关键词

-

资金

  1. NIH [P41 GM103403, S10OD021527]
  2. US Department of Energy [DE-AC02-06CH11357]
  3. Canada Foundation for Innovation
  4. Natural Sciences and Engineering Research Council of Canada
  5. University of Saskatchewan
  6. Government of Saskatchewan
  7. Western Economic Diversification Canada
  8. National Research Council Canada
  9. Canadian Institutes of Health Research
  10. AbbVie [1097737]
  11. Bayer Pharma AG [1097737]
  12. Boehringer Ingelheim [1097737]
  13. Canada Foundation for Innovation [1097737]
  14. Eshelman Institute for Innovation [1097737]
  15. Genome Canada through Ontario Genomics Institute [1097737, OGI-055]
  16. Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant] [1097737, 115766]
  17. Janssen [1097737]
  18. Merck KGaA, Darmstadt, Germany [1097737]
  19. MSD [1097737]
  20. Novartis Pharma AG [1097737]
  21. Ontario Ministry of Research, Innovation and Science (MRIS) [1097737]
  22. Pfizer [1097737]
  23. Sao Paulo Research Foundation-FAPESP [1097737]
  24. Takeda [1097737]
  25. Wellcome [1097737]
  26. Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-06300]

向作者/读者索取更多资源

The N-end rule pathway senses the N-terminal destabilizing residues of degradation substrates for the ubiquitin-proteasome system, whose integrity shields against various human syndromes including cancer and cardiovascular diseases. GID4, a subunit of the ubiquitin ligase GID complex, has been recently identified as the N-recognin of the new branch of the N-end rule pathway responsible for recognizing substrates bearing N-terminal proline residues (Pro/N-degrons). However, the molecular mechanism of GID4-mediated Pro/N-degron recognition remains largely unexplored. Here, we report the first crystal structures of human GID4 alone and in complex with various Pro/N-degrons. Our complex crystal structures, together with biophysical analyses, delineate the GID4-mediated Pro/N-degron recognition mechanism and substrate selection criteria for the Pro/N-end rule pathway. These mechanistic data on the Pro/N-recognin activity of GID4 will serve as a foundation to facilitate the identification of authentic physiological substrates as well as the development of inhibitors of therapeutic values for the Pro/N-end rule pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据